Position in INBX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$461,906
New position
Shares Held
4,875
first reported quarter
Ownership
0.033%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#93
of 161 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Persium Advisors, LLC holds $461,906 across 1 Biotechnology name. INBX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
This page
|
4,875 | $461,906 |
All Filings in INBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $461,906 | 4,875 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||